Abstract
Arterial closure devices (ACDs) were introduced in the 1990s with the advantage that patients were able to ambulate almost immediately after the procedure.1 The overall procedure time can be reduced and also patient satisfaction and acceptance has been shown to be greater.1 The StarClose device (Abbott Vascular Devices, Redwood City, CA, USA) has been shown to be efficient with a high level of clinical and technical success.2 Antegrade and retrograde punctures have been successfully sealed with the StarClose vascular device.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
